[Practice guidelines for diagnosis, treatment, and prevention of tuberculosis in patients with rheumatic disease (2025 edition)].

医学 肺结核 潜伏性肺结核 流行病学 疾病 重症监护医学 内科学 亚临床感染 家庭医学 结核分枝杆菌 病理
出处
期刊:PubMed [National Institutes of Health]
卷期号:105 (17): 1303-1321
标识
DOI:10.3760/cma.j.cn112137-20250208-00281
摘要

China is a high-burden country for tuberculosis (TB), and patients with rheumatic diseases (RD) are at significantly increased risk of TB infection and progression. Currently, there are no comprehensive clinical practice guidelines providing recommendations for the screening, diagnosis, treatment, and prevention of TB in RD patients. To address this issue, the Collaborative Group for TB Prevention and Control in Patients with RD in China, in collaboration with the Chinese Society of Clinical Epidemiology and Evidence-Based Medicine, Chinese Society of Rheumatology, Chinese Society of Tuberculosis and Chinese Society of Infectious Diseases, developed evidence-based recommendations. These were formulated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology and the Reporting Items for Practice Guidelines in Healthcare (RIGHT) standards. Based on the 14 clinical questions formed from the preliminary research, including: (1) which RD patients need to be screened for TB, (2) how to select the screening methods for TB, (3) whether to conduct re-screening for latent tuberculosis infection (LTBI) after the initial screening is negative, (4) how to diagnose and differentiate RD patients with active tuberculosis (ATB), (5) the indications and courses of empirical anti-TB treatment for RD patients suspected of ATB, (6) how to diagnose drug-resistant TB in RD patients with ATB, (7) the characteristics and management of subclinical TB in RD patients with ATB, (8) the recommended treatment regimens and courses for TB in RD patients, (9) the interaction between anti-TB drugs and RD treatment drugs and how to choose alternative regimens, (10) how to handle adverse drug reactions during anti-TB treatment in RD patients, (11) how to evaluate the effectiveness of anti-TB treatment in RD patients, (12) the indications for initiating tuberculosis preventive treatment (TPT) in RD patients, (13) the recommended regimens and courses for TPT in RD patients, (14) the protection period of TPT and whether to repeat it, detailed evidence-based recommendations were provided, aiming to offer decision support for clinical practice.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷人成协发布了新的文献求助10
刚刚
刚刚
刚刚
刚刚
1秒前
万能图书馆的应助被Dxx采纳,获得10
2秒前
orixero的应助被萌新呜呜呜采纳,获得10
2秒前
2秒前
crimson发布了新的文献求助10
3秒前
4秒前
4秒前
陈乐宁2024发布了新的文献求助10
5秒前
合适的金鑫完成签到,获得积分10
5秒前
AAAA发布了新的文献求助10
6秒前
何钦完成签到,获得积分10
6秒前
卡机了完成签到,获得积分10
7秒前
荔枝完成签到,获得积分10
7秒前
顾矜的应助被聪明的豆沙卷采纳,获得10
8秒前
9秒前
trouble虫虫发布了新的文献求助10
9秒前
秋去去发布了新的文献求助30
9秒前
科研通AI6.2的应助被cyyyyer采纳,获得10
9秒前
10秒前
现代胡萝卜完成签到 ,获得积分20
10秒前
Astra发布了新的文献求助10
10秒前
小齐明天发一区完成签到 ,获得积分10
11秒前
11秒前
脑洞疼的应助被Isla采纳,获得30
11秒前
福斯卡完成签到 ,获得积分10
11秒前
Henry完成签到,获得积分10
12秒前
12秒前
搜集达人的应助被克克采纳,获得10
12秒前
koyo完成签到,获得积分10
12秒前
13秒前
wanci的应助被白日梦采纳,获得10
13秒前
Redream完成签到,获得积分10
13秒前
13秒前
章鱼发布了新的文献求助10
14秒前
14秒前
月落南山完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183694
求助须知:如何正确求助?哪些是违规求助? 9572963
关于积分的说明 21828306
捐赠科研通 7780864
什么是DOI,文献DOI怎么找? 3434057
关于科研通互助平台的介绍 2558257
邀请新用户注册赠送积分活动 2480541